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Aim: Sarcopenia is deﬁned as the loss of skeletal muscle mass and
strength.It has been correlated with decreased survival but the role of
sarcopenia in penile cancer has not been extensively researched.We
evaluated the association between sarcopenia and mortality rates as well
as therapeutic complications in patients with metastatic penile cancer.
Method: The baseline lumbar skeletal muscle index (SMI¼ Lumbar level 3
Total Muscle Area cm2/height m2) of 38 patients with metastatic penile
cancer was measured on the ﬁrst staging computerized tomography im-
ages performed at the time of diagnosis.Sarcopenia was classiﬁed as an
SMI<55 cm2/m2.
Result: Of 38 patients, 13 (34%) were identiﬁed as having sarcopenia.There
was no signiﬁcant difference in the mean age between patients with and
without sarcopenia (mean 62 vs 60 years).Although the mortality rate was
signiﬁcantly higher in patients with sarcopenia (92% vs 60%), the median
survival did not signiﬁcantly differ (16 vs 17 months).
Conclusion: Mortality is signiﬁcantly higher in patients with metastatic
penile cancer and sarcopenia and further analysis is required to establish
the true prognostic value of sarcopenia in patients with penile cancer.-
However, this preliminary study shows that sarcopenia can be used as a
risk stratiﬁcation tool for patients with metastatic penile cancer.http://dx.doi.org/10.1016/j.ijsu.2016.08.463
0622: UROLOGY REGISTRAR OF THE WEEK: HOW DOES IT IMPROVE PA-
TIENT CARE?
M.M.A. Raza, L. Erete, S. Tadtayev, J. Bycroft T. Lane, D. Hanbury. Lister
Hospital, East & North Hertfordshire NHS Trust, UK.
Aim: To assess the effect of urology registrar of the week (ROW) rota on
patients requiring emergency urology surgery in terms of theatre waiting
times, length of stay (LOS) and readmission rate. The original ROW rota
introduced morning sessions free of elective commitments. The modiﬁed
ROW rota (introduced in January 2015) increased this to both morning and
afternoon sessions.
Method: This completing-the-cycle audit analysed a total of 180 patients
in three monthly periods: pre-ROW, post-original ROWand post-modiﬁed
ROW rota. Retrospective analysis was performed of our emergency theatre
database and inpatient computer system.
Result: There was a total of 73 emergency operations (post-modiﬁed
ROW) compared to 50 (pre-original ROW) and 57 (post-original ROW).
This contributed to a 51% increase in use of emergency theatre. Average
time from admission to theatre booking was reduced by 19%. Theatre
booking to operation time was also reduced from 7 hours (pre-ROW) to
under 5 hours (post-original ROW) and to 3 hours (post-modiﬁed ROW).
LOS and readmission rates (within 30 days) remained comparable.
Conclusion:Despite increasedemergencyprocedures, there isacorrelation in
improved patient care since the introduction of the modiﬁed ROW rota, with
reduced theatre waiting times and comparable LOS and readmission rates.http://dx.doi.org/10.1016/j.ijsu.2016.08.464
0661: LEARNING CURVE IN LAPAROSCOPIC PARTIAL NEPHRECTOMY;
NORTHERN IRELAND SINGLE SURGEON EXPERIENCE
K. Randhawa*, M.R. Evans, W. Elbaroni, J. Keane, A. Thwaini. Belfast City
Hospital, Northern Ireland, UK.
Aim: To evaluate the learning curve for laparoscopic partial nephrectomy
by a single surgeon.
Method: Retrospective review of ﬁrst twenty-four (Group 1) and last
twenty-four (Group 2) laparoscopic partial nephrectomy procedures per-
formed by a single surgeon at one institution. Learning curve was evalu-
ated by examining operative times, warm ischaemia time, estimated blood
loss, postoperative eGFR and postoperative complications.Result: There was a statistically signiﬁcant (p¼0.03) decrease in warm
ischaemia time between initial procedures compared with later proced-
ures; due to larger numbers of later procedures performed with zero
ischaemia time. This did not result in increased EBL peri-operatively (p¼
0.606). Fewer procedures were converted to open in Group 2.
Minimal increase in mean tumour size was observed between the groups
(p¼0.94). There was little difference in nephrometry score; with similar
complexity lesions performed in both groups. Operative time was similar
in both cohorts (p¼0.07).
4% of surgical margins were positive in the ﬁrst cohort compared with 8%
in second cohort. Therewas no difference in eGFR decline between the two
cohorts. Complication rates remained low in both groups.
Conclusion: The learning curve of laparoscopic partial nephrectomy
shows progression of technique towards zero ischaemia time, with no
detrimental effect on oncological outcomes.http://dx.doi.org/10.1016/j.ijsu.2016.08.465
0664: WHAT IS THE INCIDENCE OF UNSUSPECTING INCIDENTAL PROS-
TATE CANCER IN MEN UNDERGOING TRANSURETHRAL RESECTION OF
PROSTATE?
M. Hillen, C. Robinson*, A. Steenkamp, N. Lyons, L. Taylor, P. Bollina.
Western General Hospital, NHS Lothian, Edinburgh, UK.
Aim: Despite a normal prostate speciﬁc antigen (PSA) and digital rectal
exam (DRE), prostate cancer is still diagnosed following a transurethral
resection of prostate (TURP) for suspected benign disease. More men are
undergoing green light laser (GLL) ablation of the prostate without his-
tological assessment, with the potential of missing incidental prostate
cancer cases. We aimed to determine the rate of incidental prostate cancer
in men undergoing a TURP for suspected benign disease.
Method: A retrospective review was performed on all patients who un-
derwent a TURP in 2014 in a single centre. Patient demographics, pre-
operative DRE, PSA and transrectal ultrasound-guided (TRUS) biopsy, and
TURP specimen histology and Gleason Score were recorded.
Result: 169 men without known prostate cancer underwent a TURP in
2014. 24/169 (14.2%) were found to have prostate cancer. 13 of those found
to have prostate cancer had a PSA 5ng/mL.
Conclusion: In our population, the rate of incidental prostate cancer is
7.7%. All men undergoing a TURP should be counselled about the likelihood
of incidental prostate cancer. We are potentially missing a substantial
number of prostate cancer cases in those undergoing GLL and these pa-
tients should have follow-up PSA monitoring or biopsy.http://dx.doi.org/10.1016/j.ijsu.2016.08.466
0685: IS THE REPATRIATION INTO THE COMMUNITY OF MENWITH STA-
BLE PROSTATE CANCER SAFE AND ACCEPTABLE TO PATIENTS AND GEN-
ERAL PRACTITIONERS?
L. Warr 1,*, G. Warren 1, M. Mikhail 3, T. Rashid 2, M. Mikhail 2, M. Winkler 2.
1 Imperial College London School of Medicine, London, UK; 2 Imperial College
Healthcare NHS Trust, London, UK; 3Buckinghamshire Healthcare NHS Trust,
High Wycombe, UK.
Aim: Prostate cancer patients often require life-long PSA surveillance. At
our institution men with with stable prostate cancer are repatriated into
community follow-up.
This study aimed to ascertain patients' experience of their community
management as well as the views of their GPs.
Method: A telephone surveywas conducted to assess patients' satisfaction
levels, complications and preference for community or hospital follow-up.
All patients repatriated between September 2009 and July 2012 were
included. A further survey was sent to the GPs of these patients to assess
their conﬁdence in managing them.
Result: 77 out of 122 repatriated patients completed the survey. Median
follow-up was 100 weeks. 94% were satisﬁed with their follow-up regime.
75% preferred to be followed up by their GP. Therewere no cases of disease
progression attributable to repatriation. 41 GPs ﬁlled out surveys for 59
